TGF Beta as a Prognostic Biomarker of COVID-19 Severity in Patients with NAFLD—A Prospective Case–Control Study

Non-alcoholic fatty liver disease (NAFLD), the leading cause of chronic liver disease in Western countries, has been identified as a possible risk factor for COVID-19 severity. However, the immunological mechanisms by which NAFLD exacerbates COVID-19 remain unknown. Transforming growth factor-beta 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Susak, Frano, Vrsaljko, Nina, Vince, Adriana, Papic, Neven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303946/
https://www.ncbi.nlm.nih.gov/pubmed/37375073
http://dx.doi.org/10.3390/microorganisms11061571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303946/
https://www.ncbi.nlm.nih.gov/pubmed/37375073
http://dx.doi.org/10.3390/microorganisms11061571

Ejemplares similares